VIVOS THERAPEUTICS INC (VVOS) Stock Balance Sheet
NASDAQ:VVOS - Nasdaq - US92859E2072 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 6.26M | 1.64M | 3.52M | 24.03M | 18.21M | |||
| Receivables | 430.00K | 202.00K | 460.00K | 1.20M | 1.52M | |||
| Other Current Assets | 783.00K | 616.00K | 1.45M | 2.10M | 670.00K | |||
| Total Current Assets | 7.47M | 2.46M | 5.42M | 27.32M | 20.39M | |||
| Non-Current Assets | ||||||||
| PPE Net | 4.38M | 4.70M | 4.78M | 2.83M | 870.00K | |||
| Goodwill | 2.84M | 2.84M | 2.84M | 2.84M | 2.67M | |||
| Intangibles | 370.00K | 420.00K | 300.00K | 340.00K | 270.00K | |||
| Other Non-Current Assets | 216.00K | 307.00K | 370.00K | 360.00K | 310.00K | |||
| Total Non-Current Assets | 7.81M | 8.27M | 8.30M | 6.37M | 4.94M | |||
| TOTAL ASSETS | 15.28M | 10.73M | 13.72M | 33.69M | 25.33M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | 0.00 | 1.33M | 870.00K | |||
| Accrued Expenses | 2.71M | 2.81M | 2.33M | 2.85M | 1.74M | |||
| Accounts Payable | 1.10M | 2.15M | 1.41M | 920.00K | 2.28M | |||
| Other Current Liabilities | 1.17M | 2.34M | 3.07M | 2.40M | 2.94M | |||
| Total Current Liabilities | 4.98M | 7.29M | 6.81M | 7.51M | 7.82M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 300.00K | 420.00K | |||
| Other Non-Current Liabilities | 2.35M | 3.03M | 2.11M | 340.00K | 160.00K | |||
| Total Non-Current Liabilities | 2.35M | 3.03M | 2.11M | 640.00K | 590.00K | |||
| TOTAL LIABILITIES | 7.33M | 10.32M | 8.92M | 8.15M | 8.41M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -104.19M | -93.05M | -79.47M | -55.62M | -35.33M | |||
| Additional Paid In Capital | 112.14M | 93.46M | 84.27M | 81.16M | 52.25M | |||
| Common Shares | 600.00 | 200.00 | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -600.00 | -200.00 | N/A | N/A | N/A | |||
| Shares Outstanding | 5.89M | 1.83M | 920.00K | 920.00K | 730.00K | |||
| Tangible Book Value per Share | 0.81 | -1.56 | 1.80 | 24.30 | 19.15 | |||
| Total Shareholders' Equity | 7.95M | 411.00K | 4.80M | 25.54M | 16.92M | |||
| TOTAL LIABILITIES AND EQUITY | 15.28M | 10.73M | 13.72M | 33.69M | 25.33M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | 0.01 | 0.02 | |||
| Current Ratio | 1.50 | 0.34 | 0.80 | 3.64 | 2.61 | |||
| Return On Assets (ROA) | -72.86% | -126.59% | -173.83% | -60.23% | -47.61% | |||
| Return On Equity (ROE) | -140.01% | -3304.87% | -496.88% | -79.44% | -71.28% | |||
All data in USD , ROIC based on taxRate of 0.21